Whitehawk Therapeutics (WHWK) Operating Margin (2018 - 2025)
Whitehawk Therapeutics (WHWK) reported Operating Margin of 212.99% for Q1 2025, up 15152.0% year-over-year from N/an in Q1 2024, and up 18.63% quarter-over-quarter from 261.76% in Q4 2024.
Whitehawk Therapeutics (WHWK) Operating Margin (2018 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 7 years of Operating Margin data on file, last reported at 212.99% in Q1 2025.
- Operating Margin for Q1 2025 came in at 212.99%, up 15152.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 60.53% (up 19909.0% YoY), and the FY2025 annual result was 60.53%, up 19909.0% from the prior year.
- Operating Margin advanced to 212.99% in Q1 2025 per WHWK's latest filing, from 261.76% in the prior quarter.
- Over five years, Operating Margin peaked at 113.89% in Q4 2021 and troughed at 3405.83% in Q1 2021.
- A 5-year average of 517.45% and a median of 296.0% in 2022 frame the typical range for Operating Margin.
- On a YoY basis, Operating Margin climbed as much as 280705 bps in 2022 and fell as far as 18211 bps in 2022.
- A 5-year view of Operating Margin shows it stood at 113.89% in 2021, then slumped by 160 bps to 296.0% in 2022, then climbed by 5 bps to 280.02% in 2023, then grew by 7 bps to 261.76% in 2024, then climbed by 19 bps to 212.99% in 2025.
- Business Quant data shows WHWK's Operating Margin at 212.99% in Q1 2025, 261.76% in Q4 2024, and 185.98% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -212.99% |
| Dec 31, 2024 | -261.76% |
| Sep 30, 2024 | -185.98% |
| Jun 30, 2024 | -252.21% |
| Mar 31, 2024 | -364.51% |
| Dec 31, 2023 | -280.02% |
| Sep 30, 2023 | -299.53% |
| Jun 30, 2023 | -315.14% |
| Mar 31, 2023 | -286.77% |
| Dec 31, 2022 | -296.00% |
| Sep 30, 2022 | -354.20% |
| Jun 30, 2022 | -534.19% |
| Mar 31, 2022 | -598.79% |
| Dec 31, 2021 | -113.89% |
| Mar 31, 2021 | -3,405.83% |
| Dec 31, 2020 | 60.03% |
| Sep 30, 2020 | -1,152.81% |
| Jun 30, 2020 | 61.71% |
| Dec 31, 2018 | -413,534.42% |
| Sep 30, 2018 | 59.49% |